SUBJECTS : Clinical Trials | Medical Trial
Current Controlled Trials in Cardiovascular Medicine: 2004, vol: 5, issue: 1
- 1)- Ufuk Yetkin, Ozalp Karabay, Hakan Onol. Effects of oral anticoagulation with various INR levels in deep vein thrombosis cases. Current controlled trials in cardiovascular medicine. 2004, 5 (1): 1
Cited : 6Read More - 2)- Istemihan Tengiz, Ertugrul Ercan, Emil Aliyev, Cevad Sekuri, Can Duman, Imre Altuglu. Elevated levels of matrix metalloprotein-3 in patients with coronary aneurysm: A case control study. Current controlled trials in cardiovascular medicine. 2004, 5 (1): 10Cited : 16Read More
- 3)- Ramon B van Loon, Gerrit Veen, Otto Kamp, Jean Gf Bronzwaer, Cees A Visser, Frans C Visser. Early and long-term outcome of elective stenting of the infarct-related artery in patients with viability in the infarct-area: Rationale and design of the Viability-guided Angioplasty after acute Myocardial Infarction-trial (The VIAMI-trial). Current controlled trials in cardiovascular medicine. 2004, 5 (1): 11Cited : 5Read More
- 4)- John M Morgan, Laurence D Sterns, Jodi L Hanson, Kevin T Ousdigian, Mary F Otterness, Bruce L Wilkoff. A trial design for evaluation of empiric programming of implantable cardioverter defibrillators to improve patient management. Current controlled trials in cardiovascular medicine. 2004, 5 (1): 12Cited : 11Read More
- 5)- Samer Jabbour, Shmuel Ravid, Bernard Lown. Unanswered ethical and scientific questions for trials of invasive interventions for coronary disease: The case of single vessel disease. Current controlled trials in cardiovascular medicine. 2004, 5 (1): 2Cited : 1Read More
- 6)- Christopher J Boos, Ranjit S More. Anticoagulation for non-valvular atrial aibrillation - towards a new beginning with ximelagatran. Current controlled trials in cardiovascular medicine. 2004, 5 (1): 3Cited : 4Read More
- 7)- Cornel Pater. Current trends in the cardiovascular clinical trial arena (I). Current controlled trials in cardiovascular medicine. 2004, 5 (1): 4Cited : 3Read More
- 8)- Steven M Snapinn, Qi Jiang, Boris Iglewicz. Informative noncompliance in endpoint trials. Current controlled trials in cardiovascular medicine. 2004, 5 (1): 5Cited : 18Read More
- 9)- Curt D Furberg, Mark A Hall, Mary Ann Sevick. Balancing commercial and public interests. Current controlled trials in cardiovascular medicine. 2004, 5 (1): 6Cited : 3Read More
- 10)- Cornel Pater. Individualizing therapy - in search of approaches to maximize the benefit of drug treatment (II). Current controlled trials in cardiovascular medicine. 2004, 5 (1): 7Cited : 3Read More
- 11)- Cornel Pater. Equivalence and noninferiority trials - are they viable alternatives for registration of new drugs? (III). Current controlled trials in cardiovascular medicine. 2004, 5 (1): 8Cited : 17Read More
- 12)- Cornel Pater, Deepak Bhatnagar, Jean-Pascal Berrou, Joachim Luszick, Katrin Beckmann. A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design [ISRCTN55725285]. Current controlled trials in cardiovascular medicine. 2004, 5 (1): 9Cited : 5Read More
